Samsrita Labs MD, chairman, board of directors and AGM
BSE: 539267Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹12.96.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹31 Cr3,681st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 Jun 2026
- 2.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −65.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 Jun 2026
- 0.14
- Volume, BSEVolume. Shares traded on the last trading day.
- 18,216
Samsrita Labs board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonKrishnam Raju Kalidindi
- Company Secretary and Compliance OfficerM. Gita usha Rani
6 directors3 independent2 executive1 non-executive
- Krishnam Raju Kalidindi · ChairpersonExecutive · joined Dec 2016 · reappointed Dec 2024 · 1 listed board
- Suryaprakasa Rao BommisettiIndependent · joined Mar 2019 · reappointed Mar 2024 · 87 months as independent · 3 listed boards · 3 as independent · 6 committee seats, 2 as chair
- Srinivasa Rao KoyyalamudiIndependent · joined May 2025 · 13 months as independent · 1 listed board · 1 as independent · 2 committee seats
- Johnson SelvarajIndependent · joined May 2025 · 13 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 3 as chair
- K. Naga Venkata Narendra KumarExecutive · joined Jul 2021 · reappointed Jul 2024 · 1 listed board
- Annapantula VydehiNon-executive · joined Sep 2023 · 1 listed board
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- y. Rama Mohan Reddy, left 30 May 2025: Others
- A.S.S.V Srinivas, left 30 May 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 29 May 20266 of 6 present3 independent · 111 days in between
- 6 Feb 20266 of 6 present3 independent
Audit Committee
Chair Suryaprakasa Rao Bommisetti
Srinivasa Rao Koyyalamudi, Johnson Selvaraj
- 29 May 20263 of 3 present3 independent · 111 days in between
- 6 Feb 20263 of 3 present3 independent
Nomination and remuneration committee
Chair Srinivasa Rao Koyyalamudi
Suryaprakasa Rao Bommisetti, Johnson Selvaraj
- 8 Sep 20253 of 3 present3 independent
Stakeholders Relationship Committee
Chair Johnson Selvaraj
Suryaprakasa Rao Bommisetti, Srinivasa Rao Koyyalamudi
- 6 Feb 20263 of 3 present3 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- MGR & COPeer-review certificate valid to Feb 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Samsrita Labs AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Samsrita Labs share news and announcements
Annual general meeting, 10 Aug 2026
2,951 shareholders on the register on 3 Aug 2026; present: 1 promoter and 69 others; votes counted by Vivek Surana / M/S. Vivek Surana & Associates.The company's voting result (opens in a new tab)
To receive, consider and adopt: The Audited Standalone Financial Statements of the Company for the financial year ended 31st March 2026, together with the Reports of the Board of Directors and Auditor's thereon. The Audited Consolidated Financial Statements (together with two associate Companies) of the Company for the financial year ended 31st March 2026, together with the Report of the Auditor's thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.28% · promoters 76.70% · institutions 0.00% · other public 46.64%
- To appoint a director in place of Mrs. Annapantula Vydehi (DIN: 06489491) who retires by rotation and being eligible, offers herself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.28% · promoters 76.70% · institutions 0.00% · other public 46.64%
- Appointment of Mr. Ravi Kanth Naga Pattabhi Chopperla (DIN: 06812649) as a Non-Executive Director of the company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.28% · promoters 76.70% · institutions 0.00% · other public 46.64%
- Appointment of Mr. Satyanarayana Murthy Varanasi (Din: 11121911) as an Indpendent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.28% · promoters 76.70% · institutions 0.00% · other public 46.64%
- Alteration of Object Clause of Memorandum of Association of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.28% · promoters 76.70% · institutions 0.00% · other public 46.64%
- To consider the scheme of reduction of share capital of the companySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 54.28% · promoters 76.70% · institutions 0.00% · other public 46.64%
- To approve the material related party transaction with Qrops Advisory Services Private Limited, Associate Company.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 27.17% · promoters 0.00% · institutions 0.00% · other public 36.43%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesJul 2025 | 3.39 | Working capital Requirement | 0.52 | 0.52 | No |
| Preferential IssuesJul 2025 | 3.39 | Investment into New Projects or Opportunities or Ventures | 1.32 | 0.29 | No |
| Preferential IssuesJul 2025 | 3.39 | Repayment of unsecured Loans in Part to Promoter Director | 0.88 | 0.88 | No |
| Preferential IssuesJul 2025 | 3.39 | General Corporate Purpose | 0.66 | 0.57 | No |